Related Experiment Video
Updated: May 23, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
In epigenetic therapy, less is more
1USC Epigenome Center, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA 90089-9601, USA.
Abstract:
How DNA methylation inhibitors exert their anticancer effects in patients is not well understood. In the latest issue of Cancer Cell, Tsai et al. (2012) use low-dose drug treatment to induce persistent attenuation of tumorigenicity by targeting tumor-initiating cells.
Insights
Low-dose DNA methylation inhibitors can reduce cancer growth by targeting tumor-initiating cells. This study reveals a novel mechanism for these epigenetic drugs in cancer therapy.
Area of Science:
- Epigenetics
- Cancer Biology
- Pharmacology
Background:
- The precise mechanisms by which DNA methylation inhibitors achieve their anticancer effects remain unclear.
- Tumor-initiating cells are crucial for cancer development and persistence.
Discussion:
- Tsai et al. investigated the impact of low-dose drug treatment on tumor-initiating cells.
- The study observed that low-dose treatment leads to a sustained decrease in tumorigenicity.
Key Insights:
- Low-dose DNA methylation inhibitors can induce persistent attenuation of tumor-initiating cells.
- This targeted approach offers a potential strategy for long-term cancer control.
Outlook:
- Further research into epigenetic drug mechanisms could lead to more effective cancer treatments.
- Exploring low-dose epigenetic therapies may enhance patient outcomes and reduce side effects.
More Related Videos
10:28Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
09:56Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins
Published on: October 31, 2025
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Gene Therapy
Gene Therapy